Brief Research Report
Accepted on 12 Dec 2025
Dual RNA Polymerase I Inhibition with CX-5461 and BMH-21 Synergizes in Breast Cancer by Activating p53-Dependent Stress
in Anti-Cancer Drugs
Frontiers in Drug Discovery
- 179 views
Type at least 3 characters
19 articles
articles
Original Research
Published on 06 Jun 2025
Dual upregulation of miRNA-143 and miRNA-506 in non-small cell lung cancer inhibits proliferation, motility, migration, and tumor growth
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1584801
- 2,205 views
Original Research
Published on 30 May 2025
Safety and tolerability of a bevacizumab biosimilar (Effivia®) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1591991
- 1,692 views
Review
Published on 29 Jan 2025
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1520734
- 5,782 views
Review
Published on 19 Dec 2024
Targeting steroid receptor coactivators in cancer via small molecule agents
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1514412
- 2,039 views
- 2 citations
Review
Published on 30 Sep 2024
Combating cancer stem cells: RNA m6A methylation and small-molecule drug discovery
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1465222
- 3,166 views
- 4 citations
Correction
Published on 17 Apr 2024
Corrigendum: Effect of itraconazole on the safety and pharmacokinetics of antitumor SHR6390
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1397200
- 1,078 views
Original Research
Published on 11 Apr 2024
A small molecule inhibitor of leucine carboxyl methyltransferase-1 inhibits cancer cell survival
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1278163
- 3,555 views
- 1 citation
Review
Published on 11 Apr 2024
A review on dynamics of permeability-glycoprotein in efflux of chemotherapeutic drugs
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1363364
- 3,998 views
- 8 citations
Editorial
Published on 07 Feb 2024
Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1365318
- 1,637 views
- 1 citation
Original Research
Published on 22 Nov 2023
Targeting a cancer-specific LYPD3 glycoform for tumor therapy
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1298916
- 4,252 views
- 3 citations
Brief Research Report
Published on 03 Aug 2023
Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1216516
- 6,368 views
- 6 citations
Original Research
Published on 07 Jul 2023
The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1181637
- 2,312 views
Original Research
Published on 09 May 2023
Generation of a potent anti-PD-L1-CD47 bispecific antibody with a strong therapeutic and safety profile for cancer immunotherapy
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1182146
- 5,810 views
- 1 citation
Review
Published on 06 Dec 2022
Coumarin-1,2,3-triazole hybrids as leading-edge anticancer agents
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1072448
- 8,091 views
- 21 citations
Original Research
Published on 29 Nov 2022
ASK120067 (limertinib) exerts pre-clinical anti-tumor activity by inhibiting EGFR exon20 insertion
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1050687
- 3,397 views
- 2 citations
Clinical Trial
Published on 09 Sep 2022
Effect of itraconazole on the safety and pharmacokinetics of antitumor SHR6390
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.963045
- 3,326 views
- 1 citation
Brief Research Report
Published on 10 Aug 2022
Stemness inhibition by (+)-JQ1 in canine and human mammary cancer cells revealed by machine learning
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.953988
- 3,989 views
- 3 citations
Mini Review
Published on 10 Mar 2022
A Mini-Review of the Anticancer Properties of Cryptotanshinone: A Quinoid Diterpene Extracted From the Root of Salvia miotiorrhiza Bunge
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.815017
- 4,077 views
- 4 citations